PATENT CLAIM ANALYSIS

Application Number: 15987539
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "489000"]

Abstract:
The invention in suitable embodiments is directed to purified clathrin protein therapeutics. In one aspect, one or more purified clathrin protein therapeutic, formed in whole or in part from isolated, synthetic and or recombinant amino acid residues comprising in whole or in part one or more clathrin heavy chain protein and isoforms thereof, forms one or more type of therapeutic agent for treating psychiatric disorders.

Claim (Index 20):
The drug according to  claim 17 , further characterized in that some portion of the drug is further modified with at least one of an adjunct that provides treatment of psychiatric.

Metadata:
- Claim Count in Document: 97.0
- Percentile: 93.0
- Lexical Diversity: 1.61364
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11024424', '10661465', '10661466', '10660976', '14700763']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6796123993232472
- 35 USC 102 Novelty (BERT): 0.5254678063593635
- Combined Prediction Score: 0.6641979400268588
- Mean Citation Score: 193.364124
- Max Citation Score: 239.98927
- Similarity Product: 127.87178048324289

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test